Rare diseases
Investigational molecules
Locations
Back to Germany1 140 clinical trials in Hamburg, Germany across 19 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyStudy on Dose Flexibility of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis
GermanyStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
GermanyStudy Comparing Atogepant and Topiramate for Preventive Treatment in Adults with Migraine
GermanyStudy Comparing Linvoseltamab to Elotuzumab, Pomalidomide, and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma
GermanyStudy of mRNA-4157 and Pembrolizumab for Patients with High-Risk Stage II-IV Melanoma
GermanyStudy of LY3502970 for Adults with Obesity or Overweight and Type 2 Diabetes
GermanyStudy Comparing Tacrolimus Formulations for Preventing Kidney Transplant Rejection in Adults
GermanyStudy of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema
GermanyGermanyStudy on the Effectiveness and Safety of Phleum Pratense Pollen Extract for Patients with Moderate-to-Severe Grass Pollen Allergy
GermanyStudy Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma
GermanyThe busiest research cities in the country
What the registry says about research in the country
Current clinical trials focusing on innovative treatments for metastatic prostate cancer, colorectal cancer, and breast cancer. Studies are evaluating new therapeutic combinations and targeted approaches for improved patient outcomes.
Comprehensive vaccine development programs targeting respiratory syncytial virus, cytomegalovirus, and meningococcal infections. Research focuses on both adult and pediatric populations.
Groundbreaking research in treating acute cerebral ischemic stroke with innovative therapies. Studies are evaluating functional outcomes and safety profiles of new therapeutic agents.
Clinical investigations addressing vaginal atrophy and contraceptive technologies. Research includes novel delivery systems and hormone-based treatments for postmenopausal conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
